ResMed’s gross margin has climbed to 62.3%, while investors are still valuing the stock on a low 20s P/E, well below the ...

Appen is up over 60% in two days, ResMed delivered a broad Q2 beat and energy stocks are trending higher off the back of oil ...

[10:25 am] ASX 200 currently up 0.35%, hovering intraday highs and within 1.55% of its 21-Oct-25 record high. Resources ...

ASX gold miners trail bullion's 25% rally as analysts assume US$3,000/oz long-term vs US$5,500 spot. Valuations could double ...

An FY25 beat and FY26 MAU guidance sparked a 27% spike, but the stock is still down sharply from its peak and trading on ~150x earnings.

Data supplied by Morningstar and accurate on Mar 14, 2025. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...

Selling pressure pushed the ASX Information Technology sector to near two-year lows, led by sharp falls in Xero and WiseTech Global. In contrast, gold stocks extended their rally as spot prices surged ...

Uranium price rallies have often resulted in only fleeting strong performances by local uranium stocks. Will this time be any ...

Data supplied by Morningstar and accurate on Sep 16, 2025. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...

Over the past 16 reporting seasons (2008–2024), companies that beat expectations rallied an average 5.2% on the day of their result, according to analysis by Bell Potter's Richard Coppleson. That ...

ASX 200 futures are up 48 pts (+0.54%) as of 8:30 am AEDT. Here's what you need to know before the market opens.